Back to Search
KATELYN WARD, MD
MD
Surgery Physician
NPI: 1316514458Individual
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
4351048276(MI)
Research & Publications (20)
Gestational and lactational iron deficiency alters the developing striatal metabolome and associated behaviors in young rats.
PMID 17374674·J Nutr·2007
7-preclinical
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
PMID 16019946·Xenobiotica·2005
4-observational
Apparent absolute oral bioavailability in excess of 100% for a vitronectin receptor antagonist (SB-265123) in rat. II. Studies implicating transporter-mediated intestinal secretion.
PMID 15268981·Xenobiotica·2004
4-observational
Apparent absolute oral bioavailability in excess of 100% for a vitronectin receptor antagonist (SB-265123) in rat. I. Investigation of potential experimental and mechanistic explanations.
PMID 15268980·Xenobiotica·2004
4-observational
A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time.
PMID 15155552·Drug Metab Dispos·2004
4-observational
A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance.
PMID 15155551·Drug Metab Dispos·2004
4-observational
Preclinical pharmacokinetic properties of the P-glycoprotein inhibitor GF120918A (HCl salt of GF120918, 9,10-dihydro-5-methoxy-9-oxo-N-[4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]phenyl]-4-acridine-carboxamide) in the mouse, rat, dog, and monkey.
PMID 15056727·J Pharmacol Exp Ther·2004
4-observational
Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey.
PMID 14744938·Drug Metab Dispos·2004
4-observational
Enhancement of in vitro and in vivo microdialysis recovery of SB-265123 using Intralipid and Encapsin as perfusates.
PMID 12516075·Biopharm Drug Dispos·2003
7-preclinical
Pharmacokinetics of SB-247083, a potent and selective endothelin(A) receptor antagonist, in the rat, dog, and monkey.
PMID 12415574·Biopharm Drug Dispos·2002
4-observational
SB-242235, a selective inhibitor of p38 mitogen-activated protein kinase. II: in vitro and in vivo metabolism studies and pharmacokinetic extrapolation to man.
PMID 11958562·Xenobiotica·2002
4-observational
SB-242235, a selective inhibitor of p38 mitogen-activated protein kinase. I: preclinical pharmacokinetics.
PMID 11958561·Xenobiotica·2002
3-trial
Managing the stress of caring for rehabilitation patients.
PMID 11855276·Crit Care Nurs Clin North Am·2001
8-other
Preclinical pharmacokinetics of SB-203580, a potent inhibitor of p38 mitogen-activated protein kinase.
PMID 11765141·Xenobiotica·2001
7-preclinical
SB-239063, a potent and selective inhibitor of p38 map kinase: preclinical pharmacokinetics and species-specific reversible isomerization.
PMID 11683250·Pharm Res·2001
4-observational
Atrial arrhythmia suppression by atrial overdrive pacing: pacemaker Holter assessment.
PMID 11333047·Europace·2001
3-trial
Use of immunoglobulin G antibody avidity for differentiation of primary human herpesvirus 6 and 7 infections.
PMID 11230411·J Clin Microbiol·2001
8-other
Development of an in vivo preclinical screen model to estimate absorption and bioavailability of xenobiotics.
PMID 11124234·Drug Metab Dispos·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3601 W 13 MILE RD OFC
ROYAL OAK, MI 48073 - Phone
- (248) 898-2673
Quick Facts
- NPI
- 1316514458
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile